Novel genomic alterations and clonal evolution in chronic lymphocytic leukemia revealed by representational oligonucleotide microarray analysis (ROMA
Due to its prevalence, protracted natural history, and accessibility to suitable material, chronic l...
Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of...
Clonal evolution represents the natural process through which cancer cells continuously search for p...
We examined copy number changes in the genomes of B cells from 58 patients with chronic lymphocytic ...
The transforming events that lead to B-cell chronic lymphocytic leukemia (B-CLL) are unknown, and al...
The introduction of microarray analysis represents a revolution in the scientific field, allowing to...
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene us...
Knowledge of the genomic landscape of chronic lymphocytic leukemia (CLL) grows increasingly detailed...
Which genetic alterations drive tumorigenesis and how they evolve over the course of disease and the...
SummaryClonal evolution is a key feature of cancer progression and relapse. We studied intratumoral ...
Hodgkin’s lymphoma (HL) is a heterogeneous lymphoid malignancy curable in more than 80% of cases. It...
The central cause to any cancer ultimately lies in the genome and the initial alterations that resul...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. Here, we highlight importa...
Chronic lymphocytic leukaemia (CLL) remains at the forefront of the genetic analysis of human tumour...
Advances in next-generation sequencing technologies continue to unravel the cancer genome, identifyi...
Due to its prevalence, protracted natural history, and accessibility to suitable material, chronic l...
Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of...
Clonal evolution represents the natural process through which cancer cells continuously search for p...
We examined copy number changes in the genomes of B cells from 58 patients with chronic lymphocytic ...
The transforming events that lead to B-cell chronic lymphocytic leukemia (B-CLL) are unknown, and al...
The introduction of microarray analysis represents a revolution in the scientific field, allowing to...
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene us...
Knowledge of the genomic landscape of chronic lymphocytic leukemia (CLL) grows increasingly detailed...
Which genetic alterations drive tumorigenesis and how they evolve over the course of disease and the...
SummaryClonal evolution is a key feature of cancer progression and relapse. We studied intratumoral ...
Hodgkin’s lymphoma (HL) is a heterogeneous lymphoid malignancy curable in more than 80% of cases. It...
The central cause to any cancer ultimately lies in the genome and the initial alterations that resul...
Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults. Here, we highlight importa...
Chronic lymphocytic leukaemia (CLL) remains at the forefront of the genetic analysis of human tumour...
Advances in next-generation sequencing technologies continue to unravel the cancer genome, identifyi...
Due to its prevalence, protracted natural history, and accessibility to suitable material, chronic l...
Although clonal selection by genetic driver aberrations in cancer is well documented, the ability of...
Clonal evolution represents the natural process through which cancer cells continuously search for p...